Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziyi Xu

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Journal of Cancer Research and Clinical Oncology|May 10, 2020
Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomesYuxin Mu, Xuezhi Hao, Puyuan Xing, et al.
Journal of Cancer Research and Clinical Oncology|January 4, 2022
Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort studyZiyi Xu, Xuezhi Hao, Ke Yang, et al.
Frontiers in Immunology|December 1, 2022
Immunomodulatory effects of two recombinant arginine kinases in <i>Sarcoptes Scabiei</i> on host peripheral blood mononuclear cellsYanting Xu, Ziyi Xu, Xiaobin Gu, et al.
Journal of Colloid and Interface Science|December 13, 2023
Electronic structure optimizing of Ru nanoclusters via Co single atom and N, S co-doped reduced graphene oxide for accelerating water electrolysisZiyi Xu, Meiling Fan, Shifeng Tan, et al.
Frontiers in Pharmacology|December 28, 2020
Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer ApplicationJinfeng Shi, Jiaxin Li, Ziyi Xu, et al.
Thoracic Cancer|September 22, 2021
Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutationsTeng Li, Shouzheng Wang, Jianming Ying, et al.
Organic Letters|August 29, 2025
Integration of Carbonyl Groups with 1,3,4-Oxadiazoles: A Heat-Resistant Energetic Compound with Well-Balanced Performance via Heterocycle TransformationXuezhi Yu, Ziyi Xu, Jie Tang, et al.
Cancer Management and Research|March 8, 2022
Efficacy of Osimertinib After Progression of First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (<i>EGFR</i>-TKI) in <i>EGFR</i>-Mutated Lung Adenocarcinoma: A Real-World Study in Chinese PatientsZiyi Xu, Xuezhi Hao, Qi Wang, et al.
IEEE Transactions on Visualization and Computer Graphics|February 9, 2026
AnchorCrafter: Animate Cyber-Anchors Selling Your Products via Human-Object Interacting Video GenerationZiyi Xu, Ziyao Huang, Juan Cao, et al.
Archives of Biochemistry and Biophysics|April 13, 2023
Targeting the RhoA-GEF-H1 pathway of mast cells attenuates experimental airway allergyGui Yang, Jianxiang Li, Yu Liu, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Journal of Cancer Research and Clinical Oncology|May 10, 2020
Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomesYuxin Mu, Xuezhi Hao, Puyuan Xing, et al.
Journal of Cancer Research and Clinical Oncology|January 4, 2022
Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort studyZiyi Xu, Xuezhi Hao, Ke Yang, et al.
Frontiers in Immunology|December 1, 2022
Immunomodulatory effects of two recombinant arginine kinases in <i>Sarcoptes Scabiei</i> on host peripheral blood mononuclear cellsYanting Xu, Ziyi Xu, Xiaobin Gu, et al.
Journal of Colloid and Interface Science|December 13, 2023
Electronic structure optimizing of Ru nanoclusters via Co single atom and N, S co-doped reduced graphene oxide for accelerating water electrolysisZiyi Xu, Meiling Fan, Shifeng Tan, et al.
Frontiers in Pharmacology|December 28, 2020
Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer ApplicationJinfeng Shi, Jiaxin Li, Ziyi Xu, et al.
Thoracic Cancer|September 22, 2021
Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutationsTeng Li, Shouzheng Wang, Jianming Ying, et al.
Organic Letters|August 29, 2025
Integration of Carbonyl Groups with 1,3,4-Oxadiazoles: A Heat-Resistant Energetic Compound with Well-Balanced Performance via Heterocycle TransformationXuezhi Yu, Ziyi Xu, Jie Tang, et al.
Cancer Management and Research|March 8, 2022
Efficacy of Osimertinib After Progression of First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (<i>EGFR</i>-TKI) in <i>EGFR</i>-Mutated Lung Adenocarcinoma: A Real-World Study in Chinese PatientsZiyi Xu, Xuezhi Hao, Qi Wang, et al.
IEEE Transactions on Visualization and Computer Graphics|February 9, 2026
AnchorCrafter: Animate Cyber-Anchors Selling Your Products via Human-Object Interacting Video GenerationZiyi Xu, Ziyao Huang, Juan Cao, et al.
Archives of Biochemistry and Biophysics|April 13, 2023
Targeting the RhoA-GEF-H1 pathway of mast cells attenuates experimental airway allergyGui Yang, Jianxiang Li, Yu Liu, et al.
Pageof 15